25-hydroxycholecalciferol-enhanced bone maturation in the parathyroprivic state

Area of Science:

• Endocrinology
• Bone Biology
• Mineral Metabolism

Background:

• In vitro studies suggest vitamin D metabolites directly cause bone resorption (osteolysis).
• The in vivo effects of vitamin D on bone maturation and its relationship with parathyroid hormone (PTH) require further investigation.

Purpose of the Study:

• To evaluate the in vivo effect of 25-hydroxycholecalciferol (25OHD3) on bone collagen and mineral maturation.
• To determine if this effect is dependent on parathyroid hormone (PTH).

Main Methods:

• Mature rats, both sham-operated and parathyroidectomized (PTX), were treated with 25OHD3 or an oil vehicle for two weeks.
• Tibial bone mineral-collagen maturation was assessed using bromoform-toluene density gradient fractionation.
• Intestinal calcium absorption was measured via in vivo 45Ca transport.

Main Results:

• 25OHD3 significantly accelerated bone mineral and matrix maturation in PTX rats.
• This acceleration occurred without reducing total bone mineral or collagen content.
• Intestinal calcium absorption remained unchanged in response to 25OHD3 treatment.

Conclusions:

• Biologically active vitamin D metabolites stimulate bone tissue maturation.
• Parathyroid hormone (PTH) is not essential for vitamin D-mediated bone maturation.